INTRODUCTION
The prevalence of neural tube defects (NTD) in Europe is around 9 per 10,000 births making it one of the most frequent congential anomalies affecting the central nervous system 1 . NTD encompass all anomalies that are secondary to failure of closure of the neural tube. In this review, we will first summarize the embryology and some epidemiologic aspects related to NTDs. The review focuses on myelomeningocele (MMC), which is the most common distal closure defect. We will describe the secondary pathologic changes in the central and peripheral nervous system that appear later on in pregnancy and contribute to the condition's morbidity. The postnatal impact of MMC mainly depends on the upper level of the lesion. In Europe, the vast majority of parents with a fetus with prenatally diagnosed NTDs, including MMC, opt for termination of pregnancy, as they are apparently perceived as very debilitating conditions. Animal experiments have shown that prenatal surgery can reverse this sequence. This paved the way for clinical fetal surgery resulting in an apparent improvement in outcome. The results of a recent randomized trial confirmed better outcomes after fetal repair compared to postnatal repair 2 
; with
The prenatal management of neural tube defects 159 follow up for 30 months. This should prompt fetal medicine specialists to reconsider their position towards this condition as well as its prenatal repair. The fetal surgery centre in Leuven did not have a clinical programme for fetal NTD repair until the publication of the MOMS trial. In order to offer this procedure safely and effectively, we allied to a high volume centre willing to share its expertise and assist us in the first procedures. Given the maternal side effects of current open fetal surgical techniques, we have intensified our research programmes to explore minimally invasive alternatives. Below we will describe how we are implementing this.
EMBRYOLOGY RELATED TO CLOSURE DEFECTS OF THE NEURAL TUBE
The earliest morphologic response to neural induction in the embryonic ectoderm is an increase in height of the cells that later will form the central nervous system. Eighteen days after conception these cells emerge as the 'neural plate'. The plate initially becomes narrower and longer and neurulation involves the lateral folding of this plate along a midline neural groove. This acts as an anchoring point around which the two sides hinge and fold towards each other. Both sides fuse posteriorly and separate from the overlying ectodermal sheath, to form the neural tube. Closure of the neural tube starts 21-22 days after conception in the region of the earliest somites and then spreads cranially and caudally. The cranial (anterior) and caudal (posterior) neuropore close at 24 and 26 days respectively. By then, the future central nervous system looks like a cylinder sealed at both ends. This cylinder is irregularly shaped and will undergo region-specific changes to form what will later be the brain and spinal cord. The early spinal cord has a central canal and undergoes a segmental arrangement. The exiting nerve roots indicate this segmental organisation. Each level is divided into alar and basal plate regions, which correspond to later sensory and motor regions. In the first trimester of pregnancy, the spinal cord extends over the entire length of the embryo. The spinal nerves pass through the intervertebral spaces at the level of their origin. Later, the posterior part of the body outgrows the spinal cord and to a lesser extent the vertebral column. Traditionally, it has been assumed that at birth, the spinal cord terminates at lumbar vertebra 3 (L3), and by adulthood at L2. The lumbar and sacral spinal nerve roots therefore elongate significantly, causing the appearance of a horse tail or 'cauda equina'. Below that, the filum terminale connects the end of the spinal cord to the end of the dural sac. In the early fetal period, the primordial meninx is the condensed mesenchyme around the neural tube and consists of two layers. The thicker outer mesodermal layer forms the dura mater. The thinner inner (pia-arachnoid) layer is of neural crest origin and closely apposed to the neural tissue. It is composed of the pia and arachnoid mater (together referred to as leptomeninges). Within the leptomeninges, fluid filled spaces appear that will coalesce to form the subarachnoid space. Embryonic cerebrospinal fluid (CSF) is already present from 5 weeks.
Failure of closure of the cranial and caudal neuropores leads to birth defects at the level of the brain and the spinal cord, respectively. The best known manifestation of In spina bifida occulta, the spinal cord and meninges remain in place, and are covered by soft tissues. Actually the neural arch, the bony coverage is missing, which are normally induced by the roof plate of the neural tube. It is speculated that inductive factors from the neural tube or meninges cause the typical local hair growth; the barrier of the neural arches normally prevent this from happening. Spina bifida aperta is a more pronounced lesion. B: In meningocele, the dura may be locally missing, so that the arachnoid layer is bulging beneath the skin. The sac actually contains meninges and cerebrospinal fluid. The spinal cord remains in place though there may be cord abnormalities. C: In myelo-meningocele the spinal cord is bulging through the defect into the subarachnoid space. This causes more displacement and traction on spinal roots. D: Myeloschisis: the spinal cord is splayed open, with the wall of the central canal constituting the outer surface. Colour codes: yellow line is dura mater; blue line is the arachnoid membrane, blue shading refers to cerebrospinal fluid. Drawing by Myrthe Boymans (www.myrtheboymans.nl) for, and copyright by UZ Leuven, Belgium).
failure at the cranial end is anencephaly, but milder variations such as encephaloceles also exist. This review however focuses on the consequences of failure of closure at the caudal end. This again includes a range of anomalies that affect the spinal cord caused by defects in the formation of the bony and soft tissue coverage overlying the spinal cord. The degree of non fusion of the embryonic halves of the vertebral arches may be quite variable. It can range from a relatively local and closed defect (spina bifida occulta - Figure 1 A) with minimal changes in the spinal cord to an 'open' lesion. Spina bifida occulta is relatively frequent in the population and often remains undiagnosed. Of relevance here are more extensive lesions, collectively referred to as
The prenatal management of neural tube defects 161 spina bifida cystica or aperta. Through a bony defect, the meninges and/or spinal cord protrude as a cyst filled with cerebrospinal fluid.
Meningocele refers to herniation of the meninges through the open vertebral arches without obvious herniation of neural tissue ( Figure 1B) , myelomeningocele (MMC) is characterized by extrusion of the meninges and the spinal cord ( = myelum; Figure 1C ). Myeloschisis is the most severe form, where the spinal cord itself actually remains open, because of failing fusion of the neural folds ( Figure 1D ).
IN THE PRENATAL PERIOD SPINA BIFIDA IS A PROGRESSIVE DISEASE
The majority of NTD are isolated and considered multifactorial in origin, though the exact aetiology remains unknown. We refer for aetiologic mechanisms to reviews elsewhere 28 . To explain the subsequent phenotype a two hit hypothesis has been proposed. The first hit or the primary failure in the closure of the spinal canal early in embryonic life (4 th week of gestation) exposes the spinal cord and nerves to direct trauma and neurotoxic agents in the amniotic fluid. These can be considered as second hits, that progressively damage the developing nervous system. A progressive destruction of neural tissue has been confirmed by serial prenatal observations and starts with local ependymal degeneration and subsequent tissue loss at the level of the defect from 16 weeks of gestation onwards [3] [4] [5] . Typically, the cord proximal to the defect remains normal 6, 7 . However, it may be tethered at the site of the defect, leading to traction on the developing neural tissue 8, 9 . Effects are both "under" or peripheral to the lesion, as well as "above", affecting the brain. Motor and sensory deficits develop beyond the level of the defect, typically affecting the lower limbs in case of thoraco-lumbar lesions. The clinical impact is highly dependent on the level and extension of the lesion 10, 11 . Whereas local damage to the spinal cord and peripheral nerves becomes evident at birth, it remains irreversible despite immediate postnatal surgical repair. In long-term survivors major disabilities include paralysis, bowel, bladder and sexual dysfunction. The motor deficit leads to progressive orthopaedic deformities of the spine (scoliosis) and the lower limbs.
Myelomeningocele also induces progressive changes above the level of the lesion. The most important one is the Chiari II malformation, formerly referred to as the "Arnold-Chiari II" or simply CM II. This is the downward displacement of the cerebellar vermis and brain stem into the spinal canal. Moreover, elongation and compression of the brain stem, compression of the fourth ventricle and downward displacement of the venous sinuses is often seen 12 . The Chiari malformation may have a hydrostatic origin (CSF leakage at the level of the defect, leading to a 'suction gradient') 12 and has been invariably described between 19 and 25 weeks of gestation. However, as diagnosis has been shifting to the first trimester, it seems signs are already present early on. CM II can cause cerebellar, respiratory and cranial nerve dysfunction. Moreover the hindbrain herniation impairs normal circulation of CSF through the fourth ventricle, leading to secondary hydrocephalus, which in turn affects neurocognitive prognosis and late morbidity. Over 80% of children require lifelong shunting, diverting CSF to the peritoneal cavity. This procedure has well identified risks from malfunction and infection, as well as the requirement for reinsertion 13 . Around 50% of children will have shunt complications in the first year of life 14 . The majority (70%) of children with MMC have an IQ above 80, and half of them are able to live independent lives 15 . Parents nevertheless have to be prepared for a child with a significant need for care. Some health systems offer a wide range of resources, but families typically do not receive the full potential benefits 16 . We do not have recent European estimates of health costs of MMC, but in 2009, life-time medical costs in the US for a single child with a NTD were 460,923 US$, plus another 52,415 US$ for non-medical educational and developmental services 17 .
PRENATAL DIAGNOSIS AND SCREENING
The ultrasound appearance of the various manifestations of NTD are very specific, but beyond the scope of this paper 18 . The most important direct clue to MMC is a cystic mass protruding from the dorsal vertebral bodies, which show locally splayed ossification centres 19 . Lumbar lesions account for the vast majority of cases, followed by sacral, thoracic and cervical lesions. Spinal abnormalities are usually combined with variable secondary signs in the brain. These are often the first anomalies to be picked up by the ultrasonographer. They include ventriculomegaly, microcephaly, a concave shape of the frontal calvarium (lemon sign), and obliteration of the cisterna magna with either an apparently "absent" cerebellum or abnormal anterior curvature of the cerebellar hemispheres (banana sign) (Figure 2 ) 18, 20 . The lemon sign is present in about 1% of normal pregnancies and in up to 98% of cases with open spinal defect before 24 weeks, and gradually disappears thereafter 20 . The distortion or absence of the cerebellum as part of the CM II is observed in 95% of spina bifida aperta, but does not resolve with advancing gestation. Among 6 sonographic diagnostic signs for spina bifida, D'Addario et al 21 observed a small cerebellum, a small fossa posterior and an effaced cisterna magna in respectively 96%, 96% and 93% of cases. Ultrasound screening in the second trimester includes those sections of the fetal head in which the cranial signs related to open neural tube defects are clearly visible, resulting in a high detection rate even in non tertiary care centres 22, 23 . To determine the upper level, landmarks on transverse views of the spine are the most caudal rib (corresponding to T12) and the superior edge of the iliac crest (L5). Such evaluation is best done at a reference centre, as experience and case load are important factors for accuracy. More advanced imaging techniques including 3-D multiplanar, 3-D tomographic ultrasound, 4D-volume contrast imaging, and MRI may be useful, especially later in pregnancy 24 . (Figure 3 ) In the 1980s, the combination of ultrasound and maternal serum ␣-fetoprotein (MSAFP) around 16 to 18 weeks was introduced to optimize prenatal detection rate in screening programs (reviewed in 25 ). In such programmes, elevated MSAFP led to targeted ultrasound, and amniocentesis for measurement of AFP, acetylcholinesterase levels and karyotyping. Most European countries have now moved to first trimester screening, combining ultrasound measurement of the nuchal translucency (NT), assessment of the nasal bone, blood flow in the ductus venosus, in combination with maternal serum screening, which is effective in picking up 95% of major aneuplodies as well as a range of major structural anomalies. These may also include fetal spinal anomalies. From a first trimester screening viewpoint, an easily detectable marker of open spina bifida is localized within the brain in the same mid-sagittal plane of the fetal face used for assessment of NT and the nasal bone. In normal fetuses the fourth cerebral ventricle presents as an intracranial translucency (IT) parallel to the NT, while in fetuses with open spina bifida IT may be absent 26 ( Figure 4 ). This is believed to be due to caudal displacement of the cerebellum, compressing the fourth ventricle, hence it is an early manifestation of the CM II. This sign should prompt further investigation of the fetal spine and posterior brain. In the majority of open spina bifida cases there will be an increased diameter of the brain stem, as well as a decrease in the distance between the brain stem and occipital bone 27 . Prospective studies need to evaluate the value of using these first trimester features as a screening test for NTD.
EPIDEMIOLOGY OF NTD
The incidence of NTD varies worldwide, with the highest incidences in Northern China and Mexico 29 . Typical risk factors for NTD include previous history of a NTD in a sibling, maternal obesity, poorly controlled diabetes and maternal use of antiepileptic drugs. The true role of ethnicity and socio-economic factors may be difficult to distinguish, but it is clear that preventive measures play a role 3 . For instance, folic acid fortification of flour has decreased the incidence of NTD in the USA to 2-3/10,000 live births 8, 30 . The failure to completely abolish NTDs demonstrates that other poorly understood factors are also at play. The number of live born babies with MMC in the USA totals 1/3,000 31 . In Europe, where food is not fortified with folic acid, the prevalence of NTD (9/10.000 births) has not declined substantially over the last decade (Table 1 ). This suggests failure of the preventive policy 32 . Although care providers are well aware of the need for preconceptual folic acid supplementation, the majority of fertile women are either unaware of it or start supplementation only after a positive pregnancy test, which is too late from an embryologic point of view 33 . Though fortification has the support of most parent support groups contacted in Europe, there remains disbelief of the scientific evidence and doubts about safety 32, 34 . The Eurocat registry systematically records the incidence of birth defects in a representative selection of European regions (Table 2) , allowing insights into regional differences in incidence. Knowledge of the national screening policy is informative with respect to the pick-up rates by prenatal ultrasound. Outcome data include information on termination of pregnancy (TOP) rates which are dependent on national legal limitations 10 . Eurocat registration data are typically considered as representative of wider areas, rather than centres of excellence in that area 35 . The majority of European countries in 2004 offered routine prenatal screening ultrasound (one or 3 at the time of this registration there was neither a national ultrasound screening policy nor routine screening (this has changed since).] more; Table 2 ). In those where no such recommendations are present (like Ireland, Spain and Malta), scans and/or MSAFP screening are still routinely performed. In the Eurocat registry areas listed in Table 2 , 88% of NTD were detected prenatally, at a median gestational age of 17 weeks. This led to termination of pregnancy (TOP) in 88% of prenatally diagnosed cases (77% of all cases). Excluding countries where termination is illegal, the prenatal diagnosis and termination rate were 91% and 84%, respectively.
One factor potentially important for patients when considering TOP is the gestation at diagnosis. For instance, in the Netherlands the gestational age at diagnosis was 31 weeks at that time (the screening policy has subsequently changed). Late diagnosis was associated with a termination rate of only 29%. It will be interesting to see how second, and more recently, first trimester screening and diagnosis change TOP rates. Other factors must influence decision making; in Germany, where prenatal diagnosis was made at 18 weeks, only 44% of cases underwent termination. The majority of the European regions however have relatively high detection and termination rates, reflecting the public's perception of the morbidity of this condition. This is further illustrated by the fact that 7.3% of NTDs undergo late termination; also 11% of late TOPs are for NTD 36 . The high termination rates may contribute to the false perception that NTDs are uncommon, in turn causing lack of political support for food fortication programs.
Spina bifida, without other anomalies, remains the most frequent NTD in Europe with around 4.8 cases per 10,000 births (between 2005-2009). The numbers vary among regions, from 2.16 (Portugal) to 11.6/10,000 births (Germany). Of all spina bifida cases registered in the Eurocat registry, 60.5% underwent termination, 2.5% were stillborn, leaving 37% of cases live born. The recurrence risk for MMC is usually quoted to be 1.5-3%; with two affected siblings it is 5.7-12% 28, 37 . The presence of spina bifida occulta in a sibling does not increase the risk for MMC.
BRIEF HISTORY OF EXPERIMENTAL FETAL SURGERY
The combination of an early onset first hit and additional progressive damage (second hit) to otherwise largely normal neural elements led researchers to consider antenatal therapy. Fetal intervention essentially aims at isolating the defect in a leak proof way from the toxic and traumatic intrauterine environment. The potential of such a fetal intervention is confirmed by an experiment of nature. Indeed, when a spinal column defect remains covered rather than being an open lesion (as in spina bifida occulta or in the presence of a lipomyelomeningocele), fetuses do not develop the same severe sequelae as in open defects 38 . With the ability to diagnose MMC early and with high accuracy in the prenatal period, this is an attractive concept if it was shown to be effective.
Researchers started to explore the potential of fetal surgery by developing animal models for NTDs as well as surgical techniques for its repair. Finally, they documented the effects of in utero intervention as compared to controls managed after birth. Initial primate models involved the creation of a lumbar defect, which was either left untreated or closed primarily 39 . Fetal surgery avoided the occurrence of cystic lesions and neurologic deficit, but primary surgery obviously did not mimic the progressive in utero acquired changes between occurrence of the defect and an eventual repair. Meuli et al 40 at the University of San Francisco in California (UCSF) established a lamb model, where MMC was recreated by the microsurgical excision of the skin, the paraspinal mucles, the vertebral arches and the dura mater at level L1-L4 at 75 days of gestation. The lambs were then returned to the uterine cavity with reestablishment of the amniotic fluid volume. At birth these lambs had an MMC-like cystic fluid lesion, complete flaccid sensori-motor paraplegia and were incontinent of stools and urine. They lost normal neural ultrastructure (disruption of neural bundles, cord necrosis, neural tissue loss) distal to the lesion, but not proximally, comparable to what is seen in humans. Somatosensory evoked potentials were absent in the hind limbs, but they had normal latency in the forelimbs. Such observations were also made in other lower species, such as pigs, rats and rabbits with MMC-like lesions [41] [42] [43] [44] [45] [46] . In a second step, lambs with a surgically induced MMC underwent secondary repair 25 days after the initial lesion was created (day 100 of pregnancy) by reversed latissimus dorsi muscle flap and skin coverage. This resulted in near normal motor function, intact sensation and urinary and stool continence after term caesarean section 47, 48 . On histology the spinal cord, nerve roots and spinal ganglia appeared nearly normal. The teams in San Francisco and Philadelphia also showed that the CM II was reversed by intra-uterine closure 49, 50 . These experiments laid the experimental basis for fetal surgery for MMC, as they demonstrated that exposure to the intra-uterine environment reproduced similar damage as seen in clinical cases, and that prenatal closure preserved neurologic function and structural integrity. Animal experimental evidence of a fetal surgical procedure was and still is an absolute prerequisite prior to embarking on human clinical trials 51, 52 .
FIRST FETAL SURGERY FOR A NON-LIFE-THREATENING ANOMALY
Although MMC is associated with significant and irreversible morbidity, the condition is not lethal in the vast majority of cases. Contemplating fetal surgery only to prevent morbidity rather than mortality would be a paradigm shift for the fetal surgical community 53 . Indeed, any potential fetal benefit could be outweighed by procedure related complications in an otherwise healthy mother. At the moment of starting these clinical programmes, the experience with open fetal surgery had already shown that there were inherent maternal side effects of tocolysis, haemorrhage and obstetrical consequences of hysterotomy and membrane rupture, as well as fetal risks (mainly prematurity) 54, 55 . Given these risks, it would seem acceptable only to target the fetuses with NTD that have the worst prognosis, yet who could still benefit from a prenatal intervention. Fetuses without obvious established damage, e.g. those with CM II and hence at the highest risk for posterior fossa symptoms and later hydrocephaly, would therefore seem logical fetal surgery candidates.
At that time operative fetoscopy was booming, mainly to treat complications of monochorionic twins 51 . It was believed that minimally invasive access to the fetus would overcome most, if not all of the risks of open surgery 56, 57 . Several Figure 5 Artist impression of a fetoscopic myelomeningocele repair using multiple ports by percutaneous access. Initially the fetoscopic procedure was described via laparotomy by Bruner et al in 1999 61 and Farmer et al. 62 Fetoscopic repair is still practised by Kohl et al 63 . Drawing by Myrthe Boymans (www.myrtheboymans.nl) for and copyright by UZ Leuven, Belgium.
teams demonstrated the feasibility of very complex fetoscopic procedures involving dissection, suturing and ligation [58] [59] [60] . This might be one of the reasons why endoscopic coverage of MMC after maternal laparotomy, was attempted, first by Bruner et al between 1994 and 1997 ( Figure 5 ) 61 . Unfortunately, two out of four fetuses died during or following an operation under carbon dioxide insufflation. Farmer et al 62 from San Francisco also reported one out of three successful attempts of fetoscopic coverage of the defect using an Alloderm (LifeCell Corporation, Branchburg, NJ) patch. Despite a successful antenatal intervention, that baby still required a standard repair because of patch release and ended up with a VP-shunt. The other two attempts failed technically, leading to demise of one fetus, and standard postnatal surgery and VP-shunting in the other. In Europe, the group in Bonn had a comparable experience, which was only recently independently reported in detail 63, 64 . Of 19 fetoscopic procedures performed between 20 and 25 weeks, 3 procedures were abandoned and 3 fetuses or neonates eventually died. This left 13 (68%) fetuses that were successfully operated on and survived, who were matched for the level of lesion and same gestational age to postnatal repairs. In summary, the complication rate was higher in the fetal surgery group (membrane rupture, olighydramnios, chorioamnionitis), the gestational age at delivery earlier (32 vs. 39 weeks, respectively, p = 0.001), leading to a higher chance for respiratory distress syndrome. In concordance with observations after open surgery, the neurologic outcome after fetoscopic surgery was better (two gained segments, better preserved knee-jerk and anal reflexes). Despite proving the benefit of fetal intervention, the authors concluded that the currently observed complications must be addressed before considering fetoscopic surgery as a clinical alternative for MMC 64 .
OPEN FETAL SURGERY EXPERIENCE ON PATIENTS OPERATED PRIOR TO THE MOMS TRIAL
In the USA, teams converted to an open approach. Adzick et al 65 66 . A working party at the National Institutes of Health had meanwhile identified in total 27 reports on clinical procedures, with variable degrees of overlap 67 . The largest experience came from two groups. The group from CHOP reported on 50 selected patients, operated between 20 and 25 completed weeks of gestation 68, 69 . The indications and outcomes are displayed in Table 3 . None of the fetal surgeries failed and the overall survival rate was 94% (there were 3 prematurity related deaths). On follow up there was a dramatic improvement in hindbrain herniation prior to birth, and postnatal neurologic outcome compared to historical controls 65, 68, 70, 71 . The need for VP-shunting was halved, for all levels of lesions (43% vs. 84%). Over half (57%) of fetuses with thoracic or lumbar lesions demonstrated better leg function than would have been expected for the anatomical level of the defect, although 17% had worse than expected function. The Vanderbilt group initially operated on 29 patients between 24 and 30 weeks, and by 2005 they reported a total of 178 patients (Table 3) 70,72 . In a matched control study, the rates of short term prematurity-related complications were identical to the complications of premature infants born early for reasons other than fetal surgery 73 . In preparation for a nationwide trial, these 2 centres designed a retrospective cohort study, with 104 fetal and 189 postnatal repairs, in which they obtained follow-up for more than a year. Cases were stratified according to the level of the lesion and the gestational age at surgery. Again, shunt dependent-hydrocephalus was reduced after fetal repair, at least for fetuses with lesions below L2 (Figure 6 ) 74 . Conversely, lesions higher than L3 did not appear to benefit from fetal surgery. The effect of fetal repair was better when repair was done prior to or at 25 weeks, rather than later 75 . The above findings were in part the basis for the design of a randomized trial comparing prenatal to postnatal repair. During that trial there was a voluntary moratorium on open fetal surgery outside the trial. During that period, longer term follow up studies were carried out and an agreement was sought on standardization of long term outcome measures. In a 2-year follow up report on 30 prenatally operated children, the presence of a VP-shunt was correlated with a significant decrease in all testing scores. The lower shunt rate after fetal repair, together with a better outcome without a shunt more likely resulted in normal cognitive development 68 . Danzer et al 76, 77 recently reported the 5-year follow up of children at CHOP. Their mean verbal intelligence, performance intelligence and full intelligence quotient were in the normal population range. High or average scores for these were found in 90% or more, and in 60 % for processing speed. Un-shunted children had better full intelligence quotient and processing speed than those requiring a shunt. Their functional status regarding self-care, mobility and cognitive independence was lower than normal agematched controls. Complete independency was achieved by 84% (cognition), 38% (self care), 62% (mobility), and 58% total functional outcome. Again outcomes were better when no shunt was required 76, 77 . The majority of children achieve neurocognitive and neurofunctional independence. Nearly one third however continue to require maximal assistance when carrying out self-care tasks. Functional studies confirmed previous findings by other centres that showed only minimal impact of prenatal MMC surgery on continence function 78, 79 . 
THE NICHD MANAGEMENT OF MYELOMENINGOCELE STUDY
The trial, better known by its acronym "MOMS", started in 2003. It hypothesized that coverage of lesions above S1 between 19 and 25 completed weeks of gestation, improves outcome when compared to postnatal repair (1:1 randomization) 2 . All patients were managed at one of three locations in the USA (CHOP, Vanderbilt and UCSF) based on regional allocation, with a moratorium for fetal MMC repair outside the trial. The data and coordination centre was at George Washington University, where randomization also occurred. The first primary outcome was a composite of fetal or neonatal death or the need for placement of shunt by the age of 12 months. A second primary outcome at 30 months was a composite of mental development (Mental Development Index of the Bayleys Scales of Infant Development II) and motor function with adjustment for lesion level.
Preoperative work up
Patients with isolated spina bifida, considering fetal surgery were managed by a multidisciplinary team in the perioperative period. Comprehensive assessment by modern medical imaging techniques, included fetal anatomical assessment with measurement of severity indicators, such as confirmation of a thin walled cystic lesion, its level and extension, cerebral ventricular diameter, lower extremity movement and foot positioning, exclusion of spinal deformation, as well as localization of the placenta, measurement of the cervical length, and exclusion of uterine anomalies that may interfere with open fetal surgery ( Table 4 ). The karyotype should be normal. The inclusion criteria are detailed in Table 4 . These were a compromise between the very strict criteria used in Philadelphia and a more wide The prenatal management of neural tube defects 173 72, 80 . Both the anesthesiologist and the maternal-fetal medicine specialists screened for physical maternal risks 55, 81 . The results of the fetal assessment and its prognosis were then discussed with the family, as well as the potential benefits and disadvantages of fetal surgery and the alternative options. The well defined maternal risks were discussed, such as the side effects of tocolysis, including the risk of pulmonary oedema, abruptio, uterine rupture, long hospitalization, as well as the need for future caesarean delivery, prior to obtaining informed consent.
Surgical procedure
The following standardized procedure was agreed on for the MOMS trial, further detailed in the on-line available additional material 2 . Prior to the operation, cefazolin (1000 mg I.V.) and indomethacin (50 mg rectal or PO) were administered. Maternal general inhalational deep anaesthaesia and epidural anesthaesia provided adequate fetal anesthaesia and uterine relaxation for fetal surgery. In the postoperative phase analgesics were continued through the epidural catheter. A wide range of maternal monitoring techniques were used 81 . A low transverse maternal laparotomy was performed to expose the uterus. In case of an anterior placenta, the muscle layers were split so that the uterus could be exteriorized. Rarely a vertical skin incision was used in patients with a BMI>30. The hysterotomy was at least 6 cm away from the placental edge. Intraoperative ultrasound determined the fetal and placental location ( Figure 7) . The fetus was manually positioned such that the MMC sac was in the centre of the future hysterotomy. Two monofilamentary traction sutures were passed under ultrasound guidance through the uterine wall and membranes. With electrocautery the myometrial layers were split and the cavity opened. A purpose designed uterine stapling device, loaded with absorbable polyglycolic acid staples (Covidien Auto Suture, Norwalk CT) was used. This may be facilitated by a spearlike device, that snaps onto the lower limb of the uterine stapler. Prior to stapling, the operator excludes the incorporation of fetal elements or the cord by palpation and ultrasound. Two or more staplers were used to create a 6-8 cm uterine incision, large enough to expose the fetal myelomeningocele. In order to minimize the risks of placental separation, uterine contractions and expulsion of the fetus, warm Ringer's lactate was continuously infused into the cavity via a "level I" rapid infusion device (H-1200, Fast Flow Fluid Warmer, Smiths Medical ASD Incorporated, St. Paul, Minn., USA). During the entire operation, the fetal heart rate and ventricular function were continuously monitored by fetal echocardiography. This was done by a fetal medicine specialist or echocardiographer not involved in the actual surgery. The fetus was given an intramuscular injection of fentanyl (20 mcg/kg) and vecuronium (0.2mg/kg) prior to starting surgery. The actual MMC repair was not different from a postnatal repair. The neural placode was sharply dissected from surrounding tissue and allowed to drop back into the spinal canal. The dura was subsequently identified, reflected over the placode and closed using a fine running suture. If there was insufficient dura for closure, Duragen (Integra Life Sciences Corporation, Plainsboro, NJ) was used as a substitute. Finally, skin flaps are mobilized and closed to complete the watertight MMC closure. If it was not possible to obtain skin closure, relaxing incisions were made or Alloderm (Life Cell) was used. The uterus was closed in two layers, the first one incorporating the absorbable staples and uterine membranes. As the last stitches of this layer were being placed, warmed Ringer's lactate, mixed with 2 g of oxacillin or 900 mg of clindamycin, was added to the uterus until the amniotic fluid index appeared normal under ultrasound. A second imbricating layer of suture was tied. At uterine closure, intravenous magnesium sulfate was started, to be continued for 24 hours thereafter. To help achieve a watertight hysterotomy closure, the uterine wound was covered with an omental patch. Finally, the abdominal wall was closed in layers. Postoperative medication included pain relief and cefazolin. Prophylactic tocolytics included initial magnesium sulfate (24 hours), indomethacin (50 mg PR or PO 6 hourly, for 24 hours, then 25 mg 6 hourly for a total of 48 hours), with daily monitoring of the ductus arteriosus. Maintenance tocolysis by oral nifedipine (10-20 mg every 4-6 h) was initiated after discontinuiation of the magnesium until 37 weeks. Whenever needed, therapeutic tocolysis with magnesium sulfate and/or indomethacin were considered. Patients remained in hospital for around 4 postoperative days, followed by modified bed rest for 2 weeks. Follow up visits included weekly ultrasound assessment, which documented the amniotic fluid volume, the fetal membranes, the cervix, and biophysical profile. In the absence of problems, elective caesarean delivery by lower uterine incision at 37 weeks was planned.
Trial results
In December 2010 the trial was concluded at a planned interim analysis of 183 out of the 200 anticipated patients because of efficacy 2 . The results are summarized in Table 5 . In line with earlier clinical trials, fetal surgery improved MMC related infant outcomes. The first primary outcome (death or need for shunt) occurred in 68% of the infants in the prenatal surgery group and in 98% of those postnatal surgery group (n = 158). Actual rates of shunt placement were 40% in the prenatal surgery group and 82% in the postnatal surgery group. Prenatal surgery also resulted in improvement in the composite score for mental development and motor function at 30 months (n = 64; p = 0.007). On closer inspection, mental development score was not different, but there was a marked improvement in motor function. There were also improvements in several secondary outcomes, including hindbrain herniation by 12 months and ambulation by 30 months (42% of patients could walk independently after fetal surgery as compared to 21% after postnatal repair; p = 0.01). By serendipity, the lesion level in the prenatal repair group was more severe than in the postnatal group (p = 0.02), which makes the results even more remarkable.
In essence fetal surgery resulted in a level of function that is two or more levels better than what would be expected based on the anatomical lesion. These differences are not only statistically significant but also clinically relevant 82 . Overall children born after fetal surgery were less likely to have hindbrain herniation, and if they had, it was milder. Their need for surgical interventions after (fetal) coverage of the MMC was also lower, including decreased needs for VP-shunt insertion and release of tethered cord. The trial observations are consistent with earlier findings in observational studies and are thus very likely to be constant. Though long term follow up is not available yet, it is reasonable to hope for a durable outcome, as was earlier demonstrated in observational studies. The follow up of the children from this study has started. MOMS II is funding an evaluation of trial children at ages 5-9 years, hypothesizing that prenatal repair improves adaptive behaviour. Secondary outcomes of this study will be motor function, cognitive function, brain morphology and function as determined by MRI, medical outcomes, quality of life, as well as maternal reproductive functioning.
The procedure however comes at a price. There were two fetal deaths in the prenatal treatment group, one during surgery, the other due to prematurity. In a way, this was balanced in the postnatal surgery group by two additional deaths (RR: 1.03), which were due to the consequences of CM II. Delivery after fetal surgery took place at a mean of 34.1 weeks versus 37.3 weeks (p < 0.001) in the postnatal repair group, including 13% of deliveries <30 weeks versus none in controls.
There were also clinically relevant maternal complications and side effects. These included pulmonary oedema (6%; associated with aggressive tocolysis), and placental abruption. There were haemorrhagic complications at birth, requiring blood transfusion (9%). There were several prolonged hospitalizations and/or readmissions for oligohydramnios (21% vs. 4%; p = 0.001), membrane rupture (46% vs 0%; p < 0.001) and preterm delivery (79 % vs 15%; p < 0.001) 83 . One in three women undergoing fetal surgery also had an area of thinning or dehiscence of the uterine scar at the time of caesarean delivery, although none of these women formally presented with clinically ruptured uterus. The presences of uterine dehiscence may have an (as yet undefined and quantified) effect both on the index as well as future pregnancies 55 These complications are all unique to the fetal surgery group. They are serious limitations to the acceptability of fetal surgery, certainly in mothers considering subsequent pregnancies.
IMPLEMENTATION IN EUROPE
For us, the question therefore is not whether but how and how often one will offer prenatal repair in clinical practice. One potential limitation to a prompt uptake in Europe, is that the numbers will be relatively low, given the higher overall termination rates. Based on the very high termination rates, it seems that the perception in Europe that MMC is a very morbid anomaly. Though outcome is improved by fetal intervention, the disease is not necessarily cured. When counseling parents considering fetal surgery, the semantics are therefore very important. The MOMS trial has shown that outcomes are better following fetal surgery. However at the same time, 26% of antenatal operated babies continue to have mild to moderate mental retardation (mental developmental index less than 85). Also, 58 % of the children will not be able to walk without help at 30 months. Yet this is significantly better than after postnatal repair, which will result in a 33% chance of a mental developmental index < 85 and a 79% chance of not being able to walk without help at 30 months. As the current fetal surgical technique does not cure the disease entirely, it seems fair to counsel parents specifying the results using the percentages both ways (success and failure rates) and leave all options open.
Another potential obstacle is that both patients and fetal medicine specialists are relatively unfamiliar with open fetal surgery. In contrast, fetoscopy is widely accepted, but the data show that fetoscopic coverage of MMC at present does not yield similar outcomes. Fetoscopic coverage is associated with a high number of complications and technical failures, though still improving outcome 64 . For us, the logical consequence is therefore that fetal surgery should now be offered by open surgery, exactly as described in the randomized trial. Traditionally, open fetal surgery per se has not been embraced in Europe. This may well be more a reflection of a physician's attitude than the patient's perception of open fetal surgery 51 . We think this attitude should now be reconsidered. Available data ( Table 6 ) actually demonstrate that rupture and preterm delivery rates after open fetal surgery are at least comparable to those reported with what is obtained by fetoscopy in singletons in the early second half of For fetoscopic MMC repair, most of the data (n = 16) come from a detailed report (n = 16) 100 , unless specified. In that case the outcome variable could only be identified in a larger (n = 19) independent neurologic outcome report 64 . Notes and abbreviations: n.s. = not specified; 1 defined as the ability to complete the surgery as planned at first attempt; 2 death around the time of surgery or as a result of it; 3 FETO involves an elective second invasive procedure around 34 weeks in 75% of cases. In another series without this second intervention, however, the gestational age at delivery was similar (35.6 (28-38) pregnancy. The best studied procedure in that respect is that for severe congenital diaphragmatic hernia, which also carries a significant risk for preterm delivery and preterm membrane rupture. We have therefore argued to "put open fetal surgery back on the European agenda" 51 . To our knowledge only a few European centres offer open surgical MMC-repair, with few or no data being published in the peer reviewed literature 84 . Most fetal surgery centres actually limit themselves to open procedures performed on placental support (EXIT procedure). Doing this may provide a certain basis of experience, including the use of inhalational anaesthesia for maximal uterine relaxation, gaining safe and effective access to the uterus and keeping uteroplacental blood flow and gas exchange adequate. Obviously this particular operation at mid gestation is very different, and training will be required. As for any other complex surgical technique, one cannot expect to have similar outcomes from the beginning 85 . The reported surgical technique and outcomes are the result of years of experience, careful standardization and stringent case selection. The voluntary moratorium precluded other US centres from offering this procedure during the trial. Therefore other North-American centres, as well as most centres elsewhere, will have to be trained for what is to most a new procedure. There are at present no guidelines, no consensus on which fetal surgical procedures should be offered regionally, nor how training should be structured and evaluated 86 . An NIH panel has published a white paper on this, and will soon come out with recommendations for the expertise and experience required. In the absence of criteria or recommendations, we, being a referral centre for congenital anomalies including MMC, have decided to train our team in a model already in use in the USA 67 . It consists of a mix of "in-house training", whereby experienced physicians invite experts to learn from them, and, to a larger extent, "exported training", whereby our team travel to expert centres to train physicians and staff. We also have return visits to assist in the first experience. The fact that we have a high-volume fetal surgery program, with an interdisciplinary board and team, offering a variety of procedures (including EXIT experience), as well as having a large experimental program, should reduce the learning curve. Regional availability of fetal MMC surgery in selected European centres will accommodate the impracticality and financial hurdles of intercontinental travel for patients. We have discussed our plans with other regional societies, so that turnover is sufficient to maintain proficiency both in evaluation and in fetal surgery.
OTHER LESSONS FROM FETAL SURGERY EXPERIENCE
Although there is a measurable and relevant benefit of fetal surgery, it is clear that fetal surgery does not cure MMC 82, 85 . There are significant morbidities in survivors, such as a substantial need for shunting with all its consequences and not all subjects benefit from the same degree of neuromotor improvement. It is conceivable that the current technique, timing and/or selection criteria are not optimal 85 .
Selection criteria
The in utero effects are not identical for each case. For instance a number of fetuses do not display reversal of hindbrain herniation. Future follow up studies may identify prenatal predictors of inappropriate or poor response, such as extent of the lesion, ventricular diameter or limb function. One will however always have to accept that the response will be to a certain extent individual, i.e. that same severity fetuses will not ultimately have the same outcome. It is therefore very difficult to use more general prenatal predictors in the individual case. For instance, most studies point to a level dependent outcome, though spectacular outcomes have been observed in individual cases with very extensive lesions.
Technique
Technical limitations are obvious. First there is the need for laparotomy, which by itself may cause fetal side effects. As mentioned, conversion to fetoscopy does not yield comparable postnatal outcomes. The present limitations of fetoscopy (e.g. operating times, membrane rupture and prematurity, feasibility and incompleteness of the surgery, need for multiple trocars) may ultimately be overcome by additional experimental work, technologic advancement and/or experience. A dramatic improvement may come from a different technique of coverage, as already suggested by several experiments 87, 88 .
Timing
A trend for poorer outcomes with very late repairs is suggested 80 . Indeed, the defect is an embryologic one, which may of itself either be partly irreversible, or, by the time repair is (currently) done, has already caused irreversible damage to the central nervous system or peripheral nerves. Spina bifida will increasingly be diagnosed in the first trimester, but very early repairs will call for alternative technical solutions, as the current surgical procedure is barely realistic on the frail tissues present during the first half of pregnancy 89, 90 . Therefore rather than dissection of the neural placode and layered suturing of the defect, it could be replaced by temporary effective sealing of the defect and surgical repair after birth [91] [92] [93] [94] [95] . Sealants could also serve as a matrix and/or carrier for factors that stimulate epidermal growth and neovascularization. The proof of principle of such a tissue engineered approach was demonstrated by the team at CHOP, using a rodent model with retinoic acid induced fetal MMC 90, 96 . This, and other programmes 97 
